Bethea Traci N, Kitahara Cari M, Sonderman Jennifer, Patel Alpa V, Harvey Chinonye, Knutsen Synnøve F, Park Yikyung, Park Song Yi, Fraser Gary E, Jacobs Eric J, Purdue Mark P, Stolzenberg-Solomon Rachael Z, Gillanders Elizabeth M, Blot William J, Palmer Julie R, Kolonel Laurence N
Slone Epidemiology Center at Boston University, Boston, Massachusetts.
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland.
Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):2119-25. doi: 10.1158/1055-9965.EPI-14-0422. Epub 2014 Jul 13.
Pancreatic cancer is a leading cause of cancer-related mortality in the United States and both incidence and mortality are highest in African Americans. Obesity is also disproportionately high in African Americans, but limited data are available on the relation of obesity to pancreatic cancer in this population.
Seven large prospective cohort studies pooled data from African American participants. Body mass index (BMI) was calculated from self-reported height and weight at baseline. Cox regression was used to calculate HRs and 95% confidence intervals (CI) for levels of BMI relative to BMI 18.5-24.9, with adjustment for covariates. Primary analyses were restricted to participants with ≥5 years of follow-up because weight loss before diagnosis may have influenced baseline BMI in cases who died during early follow-up.
In follow-up of 239,597 participants, 897 pancreatic cancer deaths occurred. HRs were 1.08 (95% CI, 0.90-1.31) for BMI 25.0 to 29.9, 1.25 (95% CI, 0.99-1.57) for BMI 30.0 to 34.9, and 1.31 (95% CI, 0.97-1.77) for BMI ≥35.0 among those with ≥5 years of follow-up (Ptrend = 0.03). The association was evident among both sexes and was independent of a history of diabetes. A stronger association was observed among never-smokers (BMI ≥30 vs. referent: HR = 1.44; 95% CI, 1.02-2.03) than among smokers (HR = 1.16; 95% CI, 0.87-1.54; Pinteraction = 0.02).
The findings suggest that obesity is independently associated with increased pancreatic cancer mortality in African Americans.
Interventions to reduce obesity may also reduce risk of pancreatic cancer mortality, particularly among never-smokers.
在美国,胰腺癌是癌症相关死亡的主要原因,非裔美国人的发病率和死亡率最高。非裔美国人的肥胖率也不成比例地高,但关于该人群中肥胖与胰腺癌关系的数据有限。
七项大型前瞻性队列研究汇总了非裔美国参与者的数据。根据基线时自我报告的身高和体重计算体重指数(BMI)。使用Cox回归计算相对于BMI 18.5 - 24.9时BMI水平的风险比(HR)和95%置信区间(CI),并对协变量进行调整。主要分析限于随访≥5年的参与者,因为在早期随访期间死亡的病例中,诊断前的体重减轻可能影响了基线BMI。
在对239,597名参与者的随访中,发生了897例胰腺癌死亡。在随访≥5年的人群中,BMI为25.0至29.9时,HR为1.08(95%CI,0.90 - 1.31);BMI为30.0至34.9时,HR为1.25(95%CI,0.99 - 1.57);BMI≥35.0时,HR为1.31(95%CI,0.97 - 1.77)(P趋势 = 0.03)。这种关联在男女中均明显,且独立于糖尿病史。在从不吸烟者中观察到的关联更强(BMI≥30与参照组相比:HR = 1.44;95%CI,1.02 - 2.03),而在吸烟者中则较弱(HR = 1.16;95%CI,0.87 - 1.54;P交互作用 = 0.02)。
研究结果表明,肥胖与非裔美国人胰腺癌死亡率增加独立相关。
减轻肥胖的干预措施也可能降低胰腺癌死亡风险,尤其是在从不吸烟者中。